Our Licensing & Distribution Partners

Our strategic growth strategy is to leverage our commercial products and services in the United States and with synergistic international partners.

perprotech

integra

coi

protein

biolife

da-vinci

Autogenesis_Logo

Personal-Cell-Scienceslogotrans

 

fedex

rutgers_logo

uw-logo

 

UMHS_Miller1ds

200px-universita%cc%88t_wu%cc%88rzburg_logo-svg

International Licensee Partners

Cell Source

Cell Source (CS), (www.cellsource.jp) currently operates a state-of-the-art cellular processing and banking facility utilizing American CryoStem’s technologies under a licensing agreement executed in 2015. CellSource is the laboratory affiliate and processing facility for a number of spa’s and clinics in Japan that currently offer cosmetic and regenerative medicine procedures including cellular therapies, platelet rich plasma (PRP), cosmetic procedures including liposuction, tissue transfer, dermal fillers and cell and tissue banking through an established chain of surgery centers under “the Clinic” brand throughout Japan.

Founded in 2015, CellSource is leveraging their participation in the regenerative medicine market in Japan by working with American CryoStem to obtain additional regulatory approvals and expand their cellular therapy offerings.  CellSource is located in Shibuya, Tokyo, Japan.


cellsource

Health Innovative Technology Corporation Limited

Health Innovative Technology Corporation Limited (HIT) (www.healthinnotech.com) is a healthcare platform dedicated to safeguard the health of people in Greater China by introducing various innovative and scientifically proven biomedical technologies from around the world, including stem cell storage and genome diagnostic services. HIT strives to promote global development of life science and medical technology by supporting research projects around the globe. HIT imports cutting-edge life science technologies that may contribute to health prevention.

HITlogo